Archive

Synthesis of 13 moderate-evidence harm papers: 5G-band RF increased sperm DNA fragmentation in vitro; pregnancy cohort linked call time to miscarriage and growth outcomes; lifetime RFR tumor genetics support translati…

Synthesis of 13 studies (2026) spanning 6 GHz, 3.5 GHz, 2.45 GHz Wi‑Fi, 28 GHz mmWave, and real‑world base‑station proximity and smartphone use. Across mechanistic, animal, and observational evidence, multiple biologi…

Synthesis of 12 studies (2026) linking RF/EMF exposures and wireless tech use to oxidative stress, apoptosis, reproductive harm, kidney changes, sleep disruption, and base-station symptom patterns—supporting precautio…

Synthesis of three 2026 studies reporting biological effects from 6 GHz RF and 0.1 THz exposure and field EMR associations in plants. Even with low-evidence limitations, the findings underscore that thermal-only RF sa…

Synthesis of 17 high-evidence EMF/RF papers: systematic reviews and major bioassays report increased tumors in male rats, reduced male fertility (including lower pregnancy rates), and elevated risks for miscarriage an…

Across high-evidence reviews in this thread, the most consistent high-certainty harm signals involve RF-EMF carcinogenicity in male rats (glioma and malignant heart schwannoma), adverse male reproductive outcomes (inc…

This animal experiment exposed rats to 6 GHz RF-EMR from a signal generator for 4 hours/day over 6 weeks and assessed plasma oxidative stress markers and kidney histology. The RF-EMR group showed lower plasma GSH, CAT, SOD, and MDA levels than control and sham groups, while cortisol did not differ. The authors also…

This RF Safe article argues that biological effects from radiofrequency and pulsed electromagnetic fields can be interpreted through two complementary layers: Maxwell–Wagner interfacial polarization (as a direct electrodynamic mechanism at cell membranes) and an “S4–Mito-Spin” framework (as an upstream susceptibility…

A multicenter case-control study in Iran reported that self-reported prolonged mobile phone use was associated with higher odds of confirmed and suspected breast cancer status. The authors emphasize that the findings do not imply causation and note limitations including self-reported exposure and potential residual…

RF Safe argues that marketing claims such as “blocks 99% of EMF” for anti-radiation phone cases are misleading because many “lab tests” are reportedly performed on shielding fabric alone rather than on a working phone. The piece frames a phone as a “dynamic radio” and suggests real-world performance may differ from…

RF Safe argues that Media Bias/Fact Check (MBFC) downgraded RF Safe partly by citing an FDA webpage stating typical RF exposure is not supported by current evidence as a health risk, but that the cited FDA page now redirects to a general “Cell Phones” landing page. The post claims other historically cited FDA…

RF Safe criticizes Media Bias/Fact Check (MBFC) for rating it “medium credibility,” arguing MBFC relied on an FDA webpage that was later changed/redirected and on a Harvard T.H. Chan School commentary. The post claims the FDA removed categorical reassurance language about cell phone safety and frames this as…

This RF Safe commentary argues that HHS, under Secretary Robert F. Kennedy Jr., was correct to remove FDA webpages that gave broad assurances that cell phone radiation is “not dangerous.” It claims blanket safety messaging is scientifically indefensible given animal toxicology findings (notably the U.S. National…

This RF Safe commentary argues that Reuters-reported actions by HHS and FDA—launching an HHS study and removing older FDA webpages stating cellphones are “not dangerous”—should be understood as a risk-communication/scientific-integrity adjustment rather than a declaration of confirmed harm. It contends that…

This RF Safe commentary argues that if HHS and FDA pursue a “reset” on cellphone radiation policy, they should fund mechanistic, predictive biology rather than relying on literature summaries or general safety reassurances. It cites the NTP rat bioassays and a WHO-commissioned animal cancer systematic review…

This RF Safe article reports that in mid-January 2026 HHS, led by Secretary Robert F. Kennedy Jr., removed or redirected certain FDA webpages that previously conveyed strong “no-risk” conclusions about cellphone radiation. It argues the updated FDA framing emphasizes statutory duties (monitoring, testing, hazard…

This RF Safe commentary argues that dismissing the National Toxicology Program (NTP) cellphone-radiation animal findings as “too high dose” is misleading because the NTP used multiple exposure tiers, including a lowest tier described as near regulatory relevance. It also claims FDA has removed webpages containing…

RF Safe reports that HHS confirmed plans to launch a new study on cellphone radiation and that an HHS spokesperson said the FDA removed webpages with “old conclusions” while new research is undertaken to identify knowledge gaps, including for emerging technologies. The article frames the FDA webpage changes as a…

RF Safe reports that the U.S. FDA substantially revised its cellphone radiation webpages around January 15, 2026, removing or reducing prior language that broadly reassured the public about safety. The article argues the new framing more closely reflects the FDA’s statutory responsibilities under the Radiation…

RF Safe recounts a timeline of FTC actions and consumer guidance targeting phone “radiation shield” stickers/patches that claimed large reductions in exposure, arguing these products can create a false sense of security. The post cites the FTC’s February 2002 enforcement actions and consumer alert, including…

RF Safe promotes its QuantaCase (also called TruthCase) as a leading “anti-radiation” phone case for 2026, emphasizing a directional shielding design intended to deflect RF energy away from the body. The article argues the product aligns with consumer-safety guidance such as keeping phones away from the body and…